Our Network AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMO Tags: #Research #Clinical research #Oncology #Medical Oncology #AstraZeneca AstraZeneca advances its ambition to eliminate cancer as a cause of death with new data across its robust portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, 20 to 24 October 2023.
